Data Insights
                                    By  Company Name
                                
                                No Filter Selected
                                    By  Disease Name
                                
                                No Filter Selected
                                    By  Drug Name
                                
                                No Filter Selected
                                    By Themes
                                
                                No Filter Selected
                                    Showing 1 results out of 1                                
                                
                                                Data Insights
                                                
                                        INV-102 by Invirsa for Diabetic Macular Edema: Likelihood of Approval
INV-102 is under clinical development by Invirsa and currently in Phase II for Diabetic Macular Edema. According to GlobalData, Phase...
